DENNER ALEXANDER J 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Denner Alexander J
Director10% Owner
Transactions
- Award
Class A Common Stock
2024-06-18+24,311→ 148,822 total
Holdings
- 16,390,000(indirect: See Footnote)
Class A Common Stock
Footnotes (2)
- [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
- [F2]Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.